Pharmacological intervention of Atorvastatin vs. Rosvastatin in patients with Acute coronary Syndrome (ATRAS study)

Phase 4

• Conditions: Coronary Artery Disease

• Registration Number: JPRN-UMIN000004200
• Lead Sponsor: Division of cardiology, Department of Internal Medicine, Memorial Heart Center, Iwate Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-13
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion Criteria 1)stand by scheduled CABG during study period 2)valvelar heart disease 3)chronic lung disease, cor plumonale 4)poor prognosis disease (malignant tumor etc.) within 5 years 5)bilateral renal artery stenosis, one-side kidney and renal artery stenosis, high potassium (K 5.0mEq/L), renal insufficiency (creatine 3.0mg/dL), liver dysfunction (AST>100 U/L, ALT>100U/L), anemia (Hb <6.0mg/dL) 6)in pregnancy (including suspicious state) , the lactation period 7)drug allergy for HMG-CoA reductase inhibitor 8)contraindication of HMG-CoA reductase inhibitor 9)could not obtained written informed consent 10)unfavorable patient for this study protocol

Study & Design

• Study Type: Interventional
• Study Design: Not specified